Publisher
Springer Science and Business Media LLC
Subject
Library and Information Sciences,Computer Science Applications,General Social Sciences
Reference48 articles.
1. Abou-El-Enein, M., & Schneider, C. K. (2016). Deciphering the EU clinical trials regulation. Nature Biotechnology, 34(3), 231–233.
2. Adda, J., Decker, C., & Ottaviani, M. (2020). P-hacking in clinical trials and how incentives shape the distribution of results across phases. Proceedings of the National Academy of Sciences, 117(24), 13386–13392.
3. Angell, M. (2008). Industry-sponsored clinical research: A broken system. JAMA, 300(9), 1069–1071.
4. Baronikova, S., Purvis, J., Southam, E., Beeso, J., Panayi, A., & Winchester, C. (2019). Commitments by the biopharmaceutical industry to clinical trial transparency: The evolving environment. BMJ Evidence-Based Medicine, 24(5), 177–184.
5. Bastian, H. (2006). They would say that, wouldn’t they?’ A reader’s guide to author and sponsor biases in clinical research. Journal of the Royal Society of Medicine, 99(12), 611–614.